© 2004 The Royal College of Psychiatrists
Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998–2000
Department of Addictive Behaviour and Psychological Medicine, St George’s Hospital Medical School, London
Department of Addictive Behaviour and Psychological Medicine, St George’s Hospital Medical School, London
Department of Addictive Behaviour and Psychological Medicine, St George’s Hospital Medical School, London
Department of Addictive Behaviour and Psychological Medicine, St George’s Hospital Medical School, London
Department of Addictive Behaviour and Psychological Medicine, St George’s Hospital Medical School, London
Correspondence: Survjit Cheeta, Department of Addictive Behaviour and Psychological Medicine, St George’s Hospital Medical School, University of London, Cranmer Terrace, London SW17 0RE, UK. Tel: 020 8725 2635; fax: 020 8725 2914; e-mail: scheeta{at}sghms.ac.uk
Background Deaths from antidepressants continue to account for a substantial proportion of drug-related deaths.
Aims To investigate the relative toxicity of the major classes of antidepressant drugs, with the specific objective of assessing this in relation to the cause of death; and to analyse the deaths where there were multiple mentions of antidepressant drugs or other psychoactive drugs with antidepressants.
Method Mortality data were collected from the National Programme of Substance Abuse Deaths, and antidepressant prescription data were collected.
Results Mostdeaths from antidepressant drugs were suicides (80%). Tricyclic antidepressants (TCAs) accounted for more drug mentions than did other antidepressant drugs (12 per million prescriptions). Selective serotonin reuptake inhibitors (SSRIs) were associated with a significantly lower risk of toxicity, but 93% of deaths from SSRIs occurred in combination with other drugs, especially TCAs (24.5%). In ‘combination’ deaths patients were significantly more likely to have had a history of drug misuse.
Conclusions The efficacy and safety of augmentation therapy with TCAsin SSRI-resistant patients should be monitored carefully, and patients prescribed antidepressants should be screened for drug use/misuse.
Related articles in BJP:
- Highlights of this issue
- SUKHWINDER S. SHERGILL
BJP 2004 184: 1-a3.[Full Text]
This article has been cited by other articles:
 |
|
 |
|
  M. W. Doak, A. C. Nixon, D. J. Lupton, and W. S. Waring Self-poisoning in older adults: patterns of drug ingestion and clinical outcomes Age Ageing, July 1, 2009; 38(4): 407 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Anderson, I. Ferrier, R. Baldwin, P. Cowen, L Howard, G Lewis, K Matthews, R. McAllister-Williams, R. Peveler, J Scott, et al. Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines J Psychopharmacol, June 1, 2008; 22(4): 343 - 396. [Abstract] [PDF]
|
|
|
|
|
|
F. Schifano and J. Corkery Cocaine/crack cocaine consumption, treatment demand, seizures, related offences, prices, average purity levels and deaths in the UK (1990 2004) J Psychopharmacol, January 1, 2008; 22(1): 71 - 79. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Deshauer Venlafaxine (Effexor): concerns about increased risk of fatal outcomes in overdose Can. Med. Assoc. J., January 2, 2007; 176(1): 39 - 40. [Full Text] [PDF]
|
|
|
|
 |
|
 I. D Maidment, P. Lelliott, and C. Paton Medication errors in mental healthcare: a systematic review Qual. Saf. Health Care, December 1, 2006; 15(6): 409 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Blier Media pressure and patient care J Psychopharmacol, July 1, 2006; 20(4): 469 - 470. [PDF]
|
|
|
|
 |
|
 N. H. RATHOD, W. M. ADDENBROOKE, and A. F. ROSENBACH Heroin dependence in an English town: 33-year follow-up The British Journal of Psychiatry, November 1, 2005; 187(5): 421 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J Mitchell Do selective serotonin reuptake inhibitors cause suicide?: Data seem to be incorrect BMJ, May 14, 2005; 330(7500): 1149 - 1150. [Full Text]
|
|
|
|
 |
|
 B. Dubicka and I. Goodyer Should we prescribe antidepressants to children? Psychiatr. Bull., May 1, 2005; 29(5): 164 - 167. [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Edwards Newer v. older antidepressants in long-term pharmacotherapy: REVISITING... PREVENTION OF RELAPSE AND RECURRENCE OF DEPRESSION Advan. Psychiatr. Treat., May 1, 2005; 11(3): 184 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Griffiths, O. Morgan, and S. Cheeta Antidepressant-related deaths * Authors' reply The British Journal of Psychiatry, December 1, 2004; 185(6): 518 - 518. [Full Text] [PDF]
|
|
|
|
|
|
I. B. Crome and T. Myton Pharmacotherapy in dual diagnosis Advan. Psychiatr. Treat., November 1, 2004; 10(6): 413 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Other articles noted Evid. Based Ment. Health, August 1, 2004; 7(3): 67 - 68. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Wessely and R. Kerwin Suicide Risk and the SSRIs JAMA, July 21, 2004; 292(3): 379 - 381. [Full Text] [PDF]
|
|